蘇鈺凱(Su, Yu-Kai) 助理教授

Email
yks@tmu.edu.tw
現   職
外科學科 助理教授

學經歷

學 歷

畢業學校與學位[修業時間]
臺北醫學大學醫學系 學士
1997/09~2004/06

本校學術經歷

任職單位與職稱[起迄時間]
外科學科助理教授
2024/10/15~

本校兼職教學行政經歷

服務單位與職稱[起迄時間]
無資料!

其它經歷

任職單位與職稱[起迄時間]
雙和醫院神經外科主任
雙和醫院神經外科主治醫師
萬芳醫院神經外科住院醫師
2004/07~2010/06

專長與研究領域

學門領域
學術專長

論文著作

清冊下載


1. 2024 Sun CT,Yang YS,Lan CL,Tran HM,Pham TA,Chiang YH, Lin CM, Su YK, Hsieh YC, Lin JH, Sun CT, Yang YS, Lan CL, Tran HM ,Pham TA, Chiang YH, Lin CM . Age- and gender-dependent impact of titanium vertebral augmentation implants combined with cementing on subsequent vertebral fracture incidence: A comparative study with cementing alone . European Spine Journal .2024 ;(33):4513-4520

2. 2024 Luh HT,Zhu C,Kuo LT,Lo WL,Liu HW,Su YK, Su IC, Lin CM, Lai DM, Hsieh ST, Lin MC, Huang APo H. Application of Robotic Stereotactic Assistance (ROSA) for spontaneous intracerebral hematoma aspiration and thrombolytic catheter placement . Journal of the Formosan Medical Association .2024

3. 2024 Chen PY,Wei L,Su YK,Lin JH,Jang JW,Hou WH, Hsu LF, Chiu HY. Psychometric properties and factor structure of the traditional Chinese version of the Community Integration Questionnaire-Revised in traumatic brain injury survivors . International Journal of Rehabilitation Research .2024 ;(47):129-134

4. 2024 Huang TF,Su YK,Su IC,Yeh YK,Liu HW,Kan IH ,Lu YC, Chang YP, Lin CM ,Tu YK ,Tseng CH. Risk, Predictive, and Preventive Factors for Noninfectious Ventriculitis and External Ventricular Drain Infection . Neurocritical Care .2024 ;(41):109-118

5. 2023 Chen PY,Su IC,Shih CY,Liu YC,Su YK,Wei L, Luh HT, Huang HC, Tsai PS, Fan YC, Chiu HY . Effects of Neurofeedback on Cognitive Function, Productive Activity, and Quality of Life in Patients With Traumatic Brain Injury: A Randomized Controlled Trial . Neurorehabilitation and Neural Repair .2023 ;(37):277-287

6. 2023 Su IC,Su YK,Setiawan SA,Yadav VK,Fong IH,Yeh CT , Lin CM , Liu HW . NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation . International journal of molecular sciences .2023 ;(24)

7. 2022 Chen PY,Hsieh SH,Lin CK,Wei L,Su YK,Tsai PS , Chiu HY . Mental fatigue mediates the relationship between cognitive functions and return to productive activity following traumatic brain injury: a mediation analysis . Brain Injury .2022 ;(36):32-38

8. 2022 Lin MC,Liu HW,Su YK,Lo WL,Lin CM. Robot-guided versus freehand fluoroscopy-guided minimally invasive transforaminal lumbar interbody fusion: a single-institution, observational, case-control study . Neurosurgical Focus .2022 ;(52)

9. 2022 Su IC,Su YK,Chuang HY,Yadav VK,Setiawan SA,Fong IH ,Yeh CT , Huang HC , Lin CM. Ubiquitin-Specific Protease 6 n-Terminal-like Protein (USP6NL) and the Epidermal Growth Factor Receptor (EGFR) Signaling Axis Regulates Ubiquitin-Mediated DNA Repair and Temozolomide-Resistance in Glioblastoma . Biomedicines .2022 ;(10)

10. 2021 Su YK,Bamodu OA,Su IC,Pikatan NW,Fong IH,Lee WH ,Yeh CT , Chiu HY , Lin CM. Combined treatment with acalabrutinib and rapamycin inhibits glioma stem cells and promotes vascular normalization by downregulating btk/mtor/vegf signaling . Pharmaceuticals .2021 ;(14)

研究計畫

計畫名稱
113 開發晝夜節律蛋白TMEM5在膠質母細胞瘤療程中之新穎時間療法及調控機制 (延續型計劃)(1/3)
補助單位
國家科學及技術委員會

計畫名稱
112 開發晝夜節律蛋白TMEM5在膠質母細胞瘤療程中之新穎時間療法及調控機制
補助單位
國家科學及技術委員會

計畫名稱
110 探討Acalabrutinib合併mTOR抑制劑對神經膠質瘤腫瘤微環境之正常化機制及治療療效
補助單位
科技部

計畫名稱
107 臨床前評估合併Btk/mTOR抑制劑作為惡性腦瘤的治療策略
補助單位
科技部